These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 32487220)

  • 1. One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections.
    Dalton KR; Rock C; Carroll KC; Davis MF
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):78. PubMed ID: 32487220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare-acquired infections: prevention strategies.
    Fernando SA; Gray TJ; Gottlieb T
    Intern Med J; 2017 Dec; 47(12):1341-1351. PubMed ID: 29224205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study.
    Pogorzelska M; Stone PW; Larson EL
    Am J Infect Control; 2012 Oct; 40(8):696-700. PubMed ID: 23021413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.
    Johnston BL; Bryce E
    CMAJ; 2009 Mar; 180(6):627-31. PubMed ID: 19289807
    [No Abstract]   [Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units.
    Lin MY; Hayden MK
    Crit Care Med; 2010 Aug; 38(8 Suppl):S335-44. PubMed ID: 20647791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Morgan DJ; Murthy R; Munoz-Price LS; Barnden M; Camins BC; Johnston BL; Rubin Z; Sullivan KV; Shane AL; Dellinger EP; Rupp ME; Bearman G
    Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1163-72. PubMed ID: 26138329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species.
    Weber DJ; Rutala WA; Miller MB; Huslage K; Sickbert-Bennett E
    Am J Infect Control; 2010 Jun; 38(5 Suppl 1):S25-33. PubMed ID: 20569853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci].
    Hori S
    Nihon Rinsho; 2002 Nov; 60(11):2144-9. PubMed ID: 12440120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the effectiveness of cohorting to reduce transmission of healthcare-associated
    Abad CL; Barker AK; Safdar N
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):691-709. PubMed ID: 32216852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
    Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.
    Polgreen PM; Beekmann SE; Chen YY; Doern GV; Pfaller MA; Brueggemann AB; Herwaldt LA; Diekema DJ
    Infect Control Hosp Epidemiol; 2006 Mar; 27(3):252-6. PubMed ID: 16532412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of infection control strategies on rates of resistant hospital-acquired pathogens in critically ill surgical patients.
    Jayaraman SP; Askari R; Bascom M; Liu X; Rogers SO; Klompas M
    Surg Infect (Larchmt); 2014 Dec; 15(6):726-32. PubMed ID: 25496277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB; ;
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):249-60. PubMed ID: 17326014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed.
    Fukushige M; Syue LS; Morikawa K; Lin WL; Lee NY; Chen PL; Ko WC
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1211-1218. PubMed ID: 35989164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant gram-negative bacilli: A neglected healthcare crisis?
    Lautenbach E; Polk RE
    Am J Health Syst Pharm; 2007 Dec; 64(23 Suppl 14):S3-21; quiz S22-4. PubMed ID: 18029939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National survey of infection preventionists: policies for discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.
    Shenoy ES; Hsu H; Noubary F; Hooper DC; Walensky RP
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1272-5. PubMed ID: 23143372
    [No Abstract]   [Full Text] [Related]  

  • 17. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
    Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
    Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis.
    Bearman G; Abbas S; Masroor N; Sanogo K; Vanhoozer G; Cooper K; Doll M; Stevens MP; Edmond MB
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
    Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.
    Calfee DP
    Curr Opin Infect Dis; 2012 Aug; 25(4):385-94. PubMed ID: 22614523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.